Neuromuscular block with rocuronium increases tolerance of acute normovolaemic anaemia in anaesthetized pigs.

Background. Utilization of an individual patient's tolerance of anaemia is a cornerstone of any restrictive transfusion policy. Whether the use of neuromuscular block (NMB) has an effect on anaemia tolerance has not been investigated. Methods. Fourteen anaesthetized and mechanically ventilated pigs were randomized to receive either rocuronium bromide 1% (Roc-group, n=7, 0.378 ml kg-1 bolus injection, 0.1 ml kg-1 min-1 continuous infusion) or the same volume of normal saline (Sal-group, n=7). Acute normovolaemic anaemia was induced by exchange of whole blood for a 6% HES-solution (130/0.4) until a sudden decrease in total body O2 consumption (VO2) indicated a critical limitation of O2 delivery to the tissues. The Hb concentration quantified at this critical time point (HbCRIT) was defined as the primary endpoint of the protocol. Secondary endpoints were parameters of central haemodynamics, O2 transport, and tissue oxygenation. Results. HbCRIT was significantly lower in the Roc-group [2.4 (0.5) vs 3.2 (0.7) g dl-1] reflecting increased tolerance of anaemia. NMB with rocuronium bromide reduced skeletal muscle O2 consumption (mVO2) and the total body O2 extraction ratio. As cardiac index increased, body O2 consumption (VO2) decreased marginally in the Roc-group [change of VO2 relative to baseline (ΔVO2) -1.7 (0.8)% vs 3.2 (1.9)% in the Sal-group, P<0.05]. Conclusions. NMB with rocuronium bromide increases the tolerance of acute normovolaemic anaemia. The underlying mechanism probably involves a reduction in skeletal muscle O2 consumption. During acellular treatment of acute blood loss, NMB might play an adjuvant role, particularly in situations where profound normovolaemic anaemia has to be tolerated, for example, bridging an acute blood loss until compatible blood products become available for transfusion. [ABSTRACT FROM AUTHOR]